Trade Zentalis Pharmaceuticals - ZNTL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02354% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001318% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.78 |
| Open | 1.66 |
| 1-Year Change | -89.45% |
| Day's Range | 1.56 - 1.66 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | 1.78 | 0.08 | 4.71% | 1.70 | 1.79 | 1.66 |
| Mar 27, 2025 | 1.76 | -0.07 | -3.83% | 1.83 | 1.99 | 1.72 |
| Mar 26, 2025 | 1.73 | -0.07 | -3.89% | 1.80 | 1.85 | 1.72 |
| Mar 25, 2025 | 1.84 | -0.12 | -6.12% | 1.96 | 1.96 | 1.78 |
| Mar 24, 2025 | 1.95 | 0.04 | 2.09% | 1.91 | 1.98 | 1.85 |
| Mar 21, 2025 | 1.87 | 0.09 | 5.06% | 1.78 | 1.89 | 1.75 |
| Mar 20, 2025 | 1.79 | 0.07 | 4.07% | 1.72 | 1.83 | 1.72 |
| Mar 19, 2025 | 1.76 | 0.01 | 0.57% | 1.75 | 1.80 | 1.74 |
| Mar 18, 2025 | 1.74 | -0.07 | -3.87% | 1.81 | 1.81 | 1.68 |
| Mar 17, 2025 | 1.87 | 0.09 | 5.06% | 1.78 | 1.91 | 1.77 |
| Mar 14, 2025 | 1.75 | -0.04 | -2.23% | 1.79 | 1.86 | 1.74 |
| Mar 13, 2025 | 1.79 | -0.09 | -4.79% | 1.88 | 1.95 | 1.73 |
| Mar 12, 2025 | 1.93 | 0.11 | 6.04% | 1.82 | 1.95 | 1.81 |
| Mar 11, 2025 | 1.81 | 0.05 | 2.84% | 1.76 | 1.83 | 1.68 |
| Mar 10, 2025 | 1.77 | 0.00 | 0.00% | 1.77 | 1.83 | 1.68 |
| Mar 7, 2025 | 1.79 | -0.10 | -5.29% | 1.89 | 1.96 | 1.79 |
| Mar 6, 2025 | 1.90 | 0.08 | 4.40% | 1.82 | 1.98 | 1.82 |
| Mar 5, 2025 | 1.92 | 0.05 | 2.67% | 1.87 | 1.92 | 1.77 |
| Mar 4, 2025 | 1.91 | 0.02 | 1.06% | 1.89 | 1.93 | 1.83 |
| Mar 3, 2025 | 1.89 | -0.15 | -7.35% | 2.04 | 2.10 | 1.86 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Zentalis Pharmaceuticals Company profile
About Zentalis Pharmaceuticals Inc
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It is developing a pipeline of product candidates with a focus on validated oncology targets. Its lead product candidates, ZN-c5, is an oral selective estrogen receptor degrader. ZN-c5 is in a Phase I/II clinical trial for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative and ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase. ZN-c3 is in a Phase I/II clinical trial for the treatment of advanced solid tumors. Its other products include ZN-d5, a selective inhibitor of B-cell lymphoma 2, in development for the treatment of non-Hodgkin’s lymphoma and acute myelogenous leukemia; and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor, in a Phase I/II clinical trial for the treatment of advanced non-small cell lung cancer.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zentalis Pharmaceuticals Inc revenues was not reported. Net loss increased 35% to $158.7M. Higher net loss reflects Research & Development Expense - Balanci increase of 88% to $145.9M (expense), Stock-based Compensation in R&D increase from $7.3M to $20.9M (expense), Selling, General & Administrative Expens increase of 31% to $23.7M (expense).
| Industry: | Bio Therapeutic Drugs |
1359 Broadway, Suite 801
NEW YORK
NEW YORK 10018
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com